Patient Support Services Contact Us
Image: Coherus Investors

News

02/03/23
REDWOOD CITY, Calif. , Feb. 03, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective February 1, 2023 , the compensation committee of the Company’s board of directors granted options to purchase an aggregate of 22,500 shares
01/09/23
Additional Growth Driver Projected to Significantly Increase Mid-to-Long Term Revenue Potential REDWOOD CITY, Calif. , Jan. 09, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus or Coherus BioSciences , Nasdaq: CHRS) announced today that it has executed a binding term sheet with Klinge
01/04/23
REDWOOD CITY, Calif. , Jan. 04, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that senior management will present at the upcoming 41 st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023 , at 8:15 a.m. Pacific Time .